Previous work by our group has demonstrated that endostatin inhibits pulmonary artery endothelial cell proliferation and migration and promotes endothelial cell apoptosis, fundamental features driving PAH pathobiology [11]. The gene discussed is COL18A1; the disease is pulmonary arterial hypertension.